TEMODAR® contains a medicine called temozolomide. This medicine is an antitumour agent for the treatment of specific forms of brain tumours. TEMODAR® belongs to a group of medicines called cytotoxic or chemotherapy medicines. Therapeutic group: Antineoplastic preparation.

TEMODAR® capsules are indicated for the treatment of:
1. Adult patients suffering from newly diagnosed glioblastoma multiforme in a combination treatment with radiation and subsequently as monotherapy treatment;
2. Children above the age of 3 years, adolescents and adults suffering from malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma (specific forms of brain tumours), showing recurrence or progression after standard therapy;
3. TEMODAR® capsules are also indicated as first line treatment for adult patients with advanced metastatic malignant melanoma.

To read more>>

To check if our service suits your case
We need to talk

Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.

Article categories

קטגוריות המאמרים

Popular topics